0

Bloodstream Infection Testing Market by Technology and Geography - Forecast and Analysis 2021-2025

  • Published: Jun 2021
  • Pages: 120
  • SKU: IRTNTR45574
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The bloodstream infection testing market has the potential to grow by $ 3.56 bn during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 8%.

This bloodstream infection testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by Technology (Conventional testing and Non-conventional testing) and Geography (North America, Europe, Asia, and ROW). The bloodstream infection testing market report also offers information on several market vendors, including Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. among others.

What will the Bloodstream Infection Testing Market Size be in 2021?

Bloodstream-Infection-Testing-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of Bloodstream Infection Testing Market

 Get Your FREE Sample Now!

Bloodstream Infection Testing Market: Key Drivers and Trends

Based on our research output, there has been a NEUTRAL impact on the market growth during and post COVID-19 era. The increasing hospital visits is notably driving the bloodstream infection testing market growth, although factors such as high cost of instruments may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the bloodstream infection testing market industry. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.

This bloodstream infection testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Bloodstream Infection Testing Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bruker Corp.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

The vendor landscape of the bloodstream infection testing market entails successful business strategies deployed by the vendors. The bloodstream infection testing market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the bloodstream infection testing market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Bloodstream Infection Testing Market?

Bloodstream-Infection-Testing-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. US, UK, Germany, Canada, and Japan are the key markets for bloodstream infection testing market in North America. 

The report offers an up-to-date analysis of the geographical composition of the market. North America has been recording significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. Unmet needs in developing countries will facilitate the bloodstream infection testing market growth in North America over the forecast period. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.

What are the Revenue-generating Technology Segments in the Bloodstream Infection Testing Market?

Bloodstream-Infection-Testing-Market-Market-Share-by-Technology-2020-2025

To gain further insights on the market contribution of various segments Request for a FREE sample

The bloodstream infection testing market share growth by the __ segment has been significant. This report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2021-2025 and embrace technologies to improve business efficiency.

This report provides an accurate prediction of the contribution of all the segments to the growth of the bloodstream infection testing market size. Furthermore, our analysts have indicated actionable market insights on post COVID-19 impact on each segment, which is crucial to predict change in consumer demand.

Bloodstream Infection Testing Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 8%

Market growth 2021-2025

$ 3.56 billion

Market structure

Fragmented

YoY growth (%)

7.85

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 42%

Key consumer countries

US, UK, Germany, Canada, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Bloodstream Infection Testing Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive bloodstream infection testing market growth during the next five years
  • Precise estimation of the bloodstream infection testing market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the bloodstream infection testing market across North America, Europe, Asia, and ROW 
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of bloodstream infection testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Market characteristics
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Technology

    • Market segments
    • Comparison by Technology
    • Conventional testing - Market size and forecast 2020-2025
    • Non-conventional testing - Market size and forecast 2020-2025
    • Market opportunity by Technology

    Geographic Landscape

    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends

    Vendor Landscape

    • Vendor landscape
    • Landscape disruption

    Vendor Analysis

    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • Accelerate Diagnostics Inc.
    • bioMerieux SA
    • Bruker Corp.
    • Danaher Corp.
    • F. Hoffmann La Roche Ltd.
    • Grifols SA
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.

    Appendix

    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

    Research Framework

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    TechnavioINFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases
    Technavio

    TechnavioDATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts
    Technavio

    TechnavioREPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape
    Interested in this report?
    Get your FREE sample now!
    The bloodstream infection testing market growth will increase by $691.32 million during 2019-2024.
    The bloodstream infection testing market is expected to grow at a CAGR of 8.53% during 2019-2024.
    Technavio has segmented the bloodstream infection testing market by technology (Conventional testing and Non-conventional testing) and geographic (North America, Europe, Asia, and ROW).
    Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Grifols SA, Siemens Healthineers AG, Thermo Fisher Scientific Inc. are a few of the key vendors in the bloodstream infection testing market.
    North America will register the highest growth rate of 39.62% among the other regions. Therefore, the bloodstream infection testing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
    The key factors driving the bloodstream infection testing market growth are:
    • Increasing hospital visits
    • Increased adoption of automation in healthcare
    The bloodstream infection testing market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
    Safe and Secure SSL Encrypted
    Technavio

    Single User:

    2500 USD

    Technavio Get the report (PDF) sent to your email within minutes.

    Subscribe & Save

    Get lifetime access to our
    Technavio Insights

    Want to customize this report?

    This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

    We offer $1000 worth of FREE customization at the time of purchase
    Technavio
    Enquire Before Buying
    1. Home
    2. Health Care
    3. Published Report
    17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>